Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

In vitro bactericidal activity of amoxicillin combined with different cephalosporins against endocarditis-associated Enterococcus faecalis clinical isolates.

Peiffer-Smadja N, Guillotel E, Luque-Paz D, Maataoui N, Lescure FX, Cattoir V.

J Antimicrob Chemother. 2019 Sep 8. pii: dkz388. doi: 10.1093/jac/dkz388. [Epub ahead of print]

PMID:
31495901
2.

A novel genomic island harbouring lsa(E), lnu(B) genes and a defective prophage in a Streptococcus pyogenes isolate resistant to lincosamide, streptogramin A and pleuromutilin antibiotics.

Berbel D, Càmara J, García E, Tubau F, Guérin F, Giard JC, Domínguez MÁ, Cattoir V, Ardanuy C.

Int J Antimicrob Agents. 2019 Aug 30. pii: S0924-8579(19)30237-7. doi: 10.1016/j.ijantimicag.2019.08.019. [Epub ahead of print]

PMID:
31476434
3.

A nationwide survey on involvement of clinical microbiologists in antibiotic stewardship programmes in large French hospitals.

Le Maréchal M, Agrinier N, Cattoir V, Pulcini C; ABS-CM working group.

Eur J Clin Microbiol Infect Dis. 2019 Aug 8. doi: 10.1007/s10096-019-03665-1. [Epub ahead of print]

PMID:
31396831
4.

Unexpected Activity of Oral Fosfomycin against Resistant Strains of Escherichia coli in Murine Pyelonephritis.

Pourbaix A, Guérin F, Burdet C, Massias L, Chau F, Cattoir V, Fantin B.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e00903-19. doi: 10.1128/AAC.00903-19. Print 2019 Aug.

PMID:
31160291
5.

Perioperative infectious risk in urology: Management of preoperative polymicrobial urine culture. A systematic review. By the infectious disease Committee of the French Association of urology.

Vallée M, Cattoir V, Malavaud S, Sotto A, Cariou G, Arnaud P, Bugel H, Coloby P, Chartier-Kastler E, Bruyère F.

Prog Urol. 2019 Apr;29(5):253-262. doi: 10.1016/j.purol.2019.02.010. Epub 2019 Apr 5.

PMID:
30962140
6.

Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16.

Sassi M, Guérin F, Zouari A, Beyrouthy R, Auzou M, Fines-Guyon M, Potrel S, Dejoies L, Collet A, Boukthir S, Auger G, Bonnet R, Cattoir V.

J Antimicrob Chemother. 2019 Jun 1;74(6):1469-1472. doi: 10.1093/jac/dkz097.

PMID:
30897199
7.

Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States.

Mendes RE, Jones RN, Woosley LN, Cattoir V, Castanheira M.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S69-S78. doi: 10.1093/ofid/ofz004. eCollection 2019 Mar.

8.

Future antibacterial strategies: from basic concepts to clinical challenges.

Cattoir V, Felden B.

J Infect Dis. 2019 Mar 20. pii: jiz134. doi: 10.1093/infdis/jiz134. [Epub ahead of print]

PMID:
30893436
9.

In vitro antimicrobial susceptibility of equine clinical isolates from France, 2006-2016.

Duchesne R, Castagnet S, Maillard K, Petry S, Cattoir V, Giard JC, Leon A.

J Glob Antimicrob Resist. 2019 Mar 14. pii: S2213-7165(19)30071-2. doi: 10.1016/j.jgar.2019.03.006. [Epub ahead of print]

PMID:
30880244
10.

Colistin heteroresistance in Enterobacter cloacae is regulated by PhoPQ-dependent 4-amino-4-deoxy-l-arabinose addition to lipid A.

Kang KN, Klein DR, Kazi MI, Guérin F, Cattoir V, Brodbelt JS, Boll JM.

Mol Microbiol. 2019 Jun;111(6):1604-1616. doi: 10.1111/mmi.14240. Epub 2019 Apr 10.

PMID:
30873646
11.

Be careful about MICs to amoxicillin for patients with Streptococci-related infective endocarditis.

Pilmis B, Lourtet-Hascoët J, Barraud O, Piau C, Isnard C, Hery-Arnaud G, Amara M, Merens A, Farfour E, Thomas E, Jacquier H, Zahar JR, Bonnet E, Monnier AL, Cattoir V, Corvec S, Boutoille D, de Ponfilly GP, Reissier S; GMC Study Group.

Int J Antimicrob Agents. 2019 Jun;53(6):850-854. doi: 10.1016/j.ijantimicag.2019.03.002. Epub 2019 Mar 7.

PMID:
30851401
12.

Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile salts.

Delmas J, Gibold L, Faïs T, Batista S, Leremboure M, Sinel C, Vazeille E, Cattoir V, Buisson A, Barnich N, Dalmasso G, Bonnet R.

Sci Rep. 2019 Feb 18;9(1):2175. doi: 10.1038/s41598-019-38628-1.

13.

How is fosfomycin resistance developed in Escherichia coli?

Cattoir V, Guérin F.

Future Microbiol. 2018 Dec;13:1693-1696. doi: 10.2217/fmb-2018-0294. Epub 2018 Dec 11. No abstract available.

14.

Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature.

Bender JK, Cattoir V, Hegstad K, Sadowy E, Coque TM, Westh H, Hammerum AM, Schaffer K, Burns K, Murchan S, Novais C, Freitas AR, Peixe L, Del Grosso M, Pantosti A, Werner G.

Drug Resist Updat. 2018 Sep;40:25-39. doi: 10.1016/j.drup.2018.10.002. Epub 2018 Nov 2. Review.

15.

Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study.

Saint Paul LP, Ficheux M, Debruyne D, Loilier M, Bouvier N, Morello R, Verdon R, Le Blanc E, Cattoir V, Lobbedez T.

Perit Dial Int. 2018 Nov-Dec;38(6):463-466. doi: 10.3747/pdi.2017.00256.

PMID:
30413641
16.

Phage Morons Play an Important Role in Pseudomonas aeruginosa Phenotypes.

Tsao YF, Taylor VL, Kala S, Bondy-Denomy J, Khan AN, Bona D, Cattoir V, Lory S, Davidson AR, Maxwell KL.

J Bacteriol. 2018 Oct 23;200(22). pii: e00189-18. doi: 10.1128/JB.00189-18. Print 2018 Nov 15.

17.

Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli.

Berleur M, Guérin F, Massias L, Chau F, Poujade J, Cattoir V, Fantin B, de Lastours V.

J Antimicrob Chemother. 2018 Nov 1;73(11):3074-3080. doi: 10.1093/jac/dky283.

PMID:
30085154
18.

In Vitro Activity of Ceftolozane-Tazobactam against Enterobacter cloacae Complex Clinical Isolates with Different β-Lactam Resistance Phenotypes.

Robin F, Auzou M, Bonnet R, Lebreuilly R, Isnard C, Cattoir V, Guérin F.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00675-18. doi: 10.1128/AAC.00675-18. Print 2018 Sep.

19.

Evaluation of the Rapid Polymyxin NP test and its industrial version for the detection of polymyxin-resistant Enterobacteriaceae.

Jayol A, Kieffer N, Poirel L, Guérin F, Güneser D, Cattoir V, Nordmann P.

Diagn Microbiol Infect Dis. 2018 Oct;92(2):90-94. doi: 10.1016/j.diagmicrobio.2018.05.006. Epub 2018 May 16.

PMID:
29895404
20.

Elective distribution of resistance to beta-lactams among Enterobacter cloacae genetic clusters.

Garinet S, Fihman V, Jacquier H, Corvec S, Le Monnier A, Guillard T, Cattoir V, Zahar JR, Woerther PL, Carbonnelle E, Wargnier A, Kernéis S, Morand PC; GMC.

J Infect. 2018 Sep;77(3):178-182. doi: 10.1016/j.jinf.2018.05.005. Epub 2018 May 26.

PMID:
29807092
21.

Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.

Rello J, van Engelen TSR, Alp E, Calandra T, Cattoir V, Kern WV, Netea MG, Nseir S, Opal SM, van de Veerdonk FL, Wilcox MH, Wiersinga WJ.

Clin Microbiol Infect. 2018 Dec;24(12):1264-1272. doi: 10.1016/j.cmi.2018.03.011. Epub 2018 Mar 24.

PMID:
29581049
22.

Bacterial Adaptation to Antibiotics through Regulatory RNAs.

Felden B, Cattoir V.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02503-17. doi: 10.1128/AAC.02503-17. Print 2018 May. Review.

23.

Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.

Lebreton F, Valentino MD, Schaufler K, Earl AM, Cattoir V, Gilmore MS.

J Antimicrob Chemother. 2018 Jun 1;73(6):1479-1486. doi: 10.1093/jac/dky039.

24.

Exploring the Antimicrobial Action of Quaternary Amines against Acinetobacter baumannii.

Knauf GA, Cunningham AL, Kazi MI, Riddington IM, Crofts AA, Cattoir V, Trent MS, Davies BW.

MBio. 2018 Feb 6;9(1). pii: e02394-17. doi: 10.1128/mBio.02394-17.

25.

In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.

Isnard C, Dhalluin A, Malandain D, Bruey Q, Auzou M, Michon J, Giard JC, Guérin F, Cattoir V.

J Glob Antimicrob Resist. 2018 Jun;13:221-225. doi: 10.1016/j.jgar.2018.01.022. Epub 2018 Feb 5.

PMID:
29421316
26.

Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.

Sassi M, Guérin F, Lesec L, Isnard C, Fines-Guyon M, Cattoir V, Giard JC.

J Antimicrob Chemother. 2018 Apr 1;73(4):852-855. doi: 10.1093/jac/dkx510.

27.

In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.

Reissier S, Saleh-Mghir A, Guerin F, Massias L, Ghout I, Sinel C, Cattoir V, Cremieux AC.

J Antimicrob Chemother. 2018 Apr 1;73(4):981-986. doi: 10.1093/jac/dkx499.

PMID:
29329389
28.

Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patients.

de Lastours V, Goulenok T, Guérin F, Jacquier H, Eyma C, Chau F, Cattoir V, Fantin B.

Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):417-421. doi: 10.1007/s10096-018-3186-x. Epub 2018 Jan 10.

PMID:
29318461
29.

Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study.

Pilmis B, Cattoir V, Lecointe D, Limelette A, Grall I, Mizrahi A, Marcade G, Poilane I, Guillard T, Bourgeois Nicolaos N, Zahar JR, Le Monnier A.

J Hosp Infect. 2018 Mar;98(3):247-252. doi: 10.1016/j.jhin.2017.11.022. Epub 2017 Dec 6.

PMID:
29222035
30.

Biological cost of fosfomycin resistance in Escherichia coli in a murine model of urinary tract infection.

Pourbaix A, Guérin F, Lastours V, Chau F, Auzou M, Boulley E, Cattoir V, Fantin B.

Int J Med Microbiol. 2017 Dec;307(8):452-459. doi: 10.1016/j.ijmm.2017.09.019. Epub 2017 Sep 29.

PMID:
28986014
31.

Comparison of MALDI-ToF MS with the Rapidec Carba NP test for the detection of carbapenemase-producing Enterobacteriaceae.

Choquet M, Guiheneuf R, Castelain S, Cattoir V, Auzou M, Pluquet E, Decroix V.

Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):149-155. doi: 10.1007/s10096-017-3115-4. Epub 2017 Oct 4.

PMID:
28980084
32.

In vitro activity of tedizolid and comparator agents against Gram-positive pathogens responsible for bone and joint infections.

Ract P, Piau-Couapel C, Compain F, Auzou M, Michon J, Cattoir V.

J Med Microbiol. 2017 Oct;66(10):1374-1378. doi: 10.1099/jmm.0.000595. Epub 2017 Sep 18.

PMID:
28920854
33.

Small RNAs in vancomycin-resistant Enterococcus faecium involved in daptomycin response and resistance.

Sinel C, Augagneur Y, Sassi M, Bronsard J, Cacaci M, Guérin F, Sanguinetti M, Meignen P, Cattoir V, Felden B.

Sci Rep. 2017 Sep 11;7(1):11067. doi: 10.1038/s41598-017-11265-2.

34.

Nationwide molecular epidemiology of methicillin-resistant Staphylococcus aureus responsible for horse infections in France.

Guérin F, Fines-Guyon M, Meignen P, Delente G, Fondrinier C, Bourdon N, Cattoir V, Léon A.

BMC Microbiol. 2017 May 3;17(1):104. doi: 10.1186/s12866-016-0924-z.

35.

Clinical and microbiological features associated with group B Streptococcus bone and joint infections, France 2004-2014.

Kernéis S, Plainvert C, Barnier JP, Tazi A, Dmytruk N, Gislain B, Loubinoux J, El Sayed F, Cattoir V, Desplaces N, Vernet V, Morand P, Poyart C.

Eur J Clin Microbiol Infect Dis. 2017 Sep;36(9):1679-1684. doi: 10.1007/s10096-017-2983-y. Epub 2017 Apr 26.

PMID:
28447173
36.

Bacterial epidemiology and antimicrobial resistance profiles of urinary specimens of the elderly.

Gravey F, Loggia G, de La Blanchardière A, Cattoir V.

Med Mal Infect. 2017 Jun;47(4):271-278. doi: 10.1016/j.medmal.2017.03.002. Epub 2017 Apr 10.

PMID:
28408060
37.

Decrease of Staphylococcus aureus Virulence by Helcococcus kunzii in a Caenorhabditis elegans Model.

Ngba Essebe C, Visvikis O, Fines-Guyon M, Vergne A, Cattoir V, Lecoustumier A, Lemichez E, Sotto A, Lavigne JP, Dunyach-Remy C.

Front Cell Infect Microbiol. 2017 Mar 16;7:77. doi: 10.3389/fcimb.2017.00077. eCollection 2017.

38.

Ecological impact of ciprofloxacin on commensal enterococci in healthy volunteers.

de Lastours V, Maugy E, Mathy V, Chau F, Rossi B, Guérin F, Cattoir V, Fantin B; CIPHARES Study Group.

J Antimicrob Chemother. 2017 Jun 1;72(6):1574-1580. doi: 10.1093/jac/dkx043.

PMID:
28333351
39.

Emergence of a novel Enterobacter kobei clone carrying chromosomal-encoded CTX-M-12 with diversified pathogenicity in northeast China.

Zhou K, Yu W, Bonnet R, Cattoir V, Shen P, Wang B, Rossen JW, Xiao Y.

New Microbes New Infect. 2017 Jan 24;17:7-10. doi: 10.1016/j.nmni.2017.01.006. eCollection 2017 May. No abstract available.

40.

Subinhibitory Concentrations of Ciprofloxacin Enhance Antimicrobial Resistance and Pathogenicity of Enterococcus faecium.

Sinel C, Cacaci M, Meignen P, Guérin F, Davies BW, Sanguinetti M, Giard JC, Cattoir V.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02763-16. doi: 10.1128/AAC.02763-16. Print 2017 May.

41.

Inventory of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France as Assessed by a Multicenter Study.

Robin F, Beyrouthy R, Bonacorsi S, Aissa N, Bret L, Brieu N, Cattoir V, Chapuis A, Chardon H, Degand N, Doucet-Populaire F, Dubois V, Fortineau N, Grillon A, Lanotte P, Leyssene D, Patry I, Podglajen I, Recule C, Ros A, Colomb-Cotinat M, Ponties V, Ploy MC, Bonnet R.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e01911-16. doi: 10.1128/AAC.01911-16. Print 2017 Mar.

42.

In vivo emergence of rifampicin resistance by rpoB mutation in Listeria monocytogenes during therapy of prosthetic joint infection.

Isnard C, Fines-Guyon M, Toublet FX, Guerin F, Rogowski C, Vergnaud M, Cattoir V.

Int J Antimicrob Agents. 2016 Nov;48(5):572-574. doi: 10.1016/j.ijantimicag.2016.07.016. Epub 2016 Sep 8. No abstract available.

PMID:
27659120
43.

Intrinsic colistin resistance.

Zhou K, Cattoir V, Xiao Y.

Lancet Infect Dis. 2016 Nov;16(11):1227-1228. doi: 10.1016/S1473-3099(16)30394-2. No abstract available.

PMID:
27788985
44.

Use of ESwab in the Xpert® vanA/vanB PCR assay.

Rasoanandrasana S, Decousser JW, Cattoir V, Berçot B, Domrane C, Fihman V, Grillon A, Lesenne A, Raskine L, Cambau E, Jacquier H.

Eur J Clin Microbiol Infect Dis. 2017 Apr;36(4):755-756. doi: 10.1007/s10096-016-2818-2. Epub 2016 Oct 26. No abstract available.

PMID:
27785637
45.

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

Daillère R, Vétizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CPM, Flament C, Lepage P, Roberti MP, Routy B, Jacquelot N, Apetoh L, Becharef S, Rusakiewicz S, Langella P, Sokol H, Kroemer G, Enot D, Roux A, Eggermont A, Tartour E, Johannes L, Woerther PL, Chachaty E, Soria JC, Golden E, Formenti S, Plebanski M, Madondo M, Rosenstiel P, Raoult D, Cattoir V, Boneca IG, Chamaillard M, Zitvogel L.

Immunity. 2016 Oct 18;45(4):931-943. doi: 10.1016/j.immuni.2016.09.009. Epub 2016 Oct 4.

46.

Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations.

Fiaux E, Titecat M, Robineau O, Lora-Tamayo J, El Samad Y, Etienne M, Frebourg N, Blondiaux N, Brunschweiler B, Dujardin F, Beltrand E, Loiez C, Cattoir V, Canarelli JP, Hulet C, Valette M, Nguyen S, Caron F, Migaud H, Senneville E; G4 bone and joint infection study group (G4BJIS).

BMC Infect Dis. 2016 Oct 13;16(1):568.

47.

First nosocomial outbreak of vanA-type vancomycin-resistant Enterococcus raffinosus in France.

Jolivet S, Fines-Guyon M, Nebbad B, Merle JC, Le Pluart D, Brun-Buisson C, Decousser JW, Cattoir V.

J Hosp Infect. 2016 Dec;94(4):346-350. doi: 10.1016/j.jhin.2016.09.004. Epub 2016 Sep 15.

PMID:
27726900
48.

A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii.

Boll JM, Crofts AA, Peters K, Cattoir V, Vollmer W, Davies BW, Trent MS.

Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6228-E6237. Epub 2016 Sep 28.

49.

Pharmacokinetics of Intraperitoneal Daptomycin in Patients with Peritoneal Dialysis-Related Peritonitis.

Peyro Saint Paul L, Ficheux M, Debruyne D, Loilier M, Bouvier N, Morello R, Parienti JJ, Verdon R, Fournel F, Cattoir V, Lobbedez T.

Perit Dial Int. 2017 Jan 2;37(1):44-50. doi: 10.3747/pdi.2016.00028. Epub 2016 Sep 28.

PMID:
27680760
50.

Mutant prevention concentrations of daptomycin for Enterococcus faecium clinical isolates.

Sinel C, Jaussaud C, Auzou M, Giard JC, Cattoir V.

Int J Antimicrob Agents. 2016 Oct;48(4):449-52. doi: 10.1016/j.ijantimicag.2016.07.006. Epub 2016 Aug 11.

PMID:
27546218

Supplemental Content

Loading ...
Support Center